“The orthobiologics market projected to grow at a CAGR of 5.4%.”
The global orthobiologics market is projected to reach USD 6.06 billion by 2022 from USD 4.66 billion in 2017, at a CAGR of 5.4%. Factors such as rising burden of orthopedic injuries; increasing incidence of sports injuries and road accidents; increasing incidence of spinal fusion surgeries; risk factors associated with increasing aging population, obesity rate, & high incidence of musculoskeletal disorders; and growing patient preference for minimally invasive procedures are driving the orthobiologics market. However, high cost pertaining to orthobiologics based treatment is the major factor restraining the market growth to a certain extent.
“The PRP segment is expected to grow at the highest rate during the forecast period.”
The PRP market is expected to grow at the highest CAGR during the forecast period. The advantages of PRP (such as reduced hospital stay) over other products used in bone stimulation are expected to drive the growth of this market. Additionally, the increasing use of PRP in sports injuries and the growing number of clinical trials to expand the application areas of PRP are expected to support the growth of this market during the forecast period.
“The spinal fusion segment is expected to grow at the highest CAGR.”
Based on applications, the orthobiologics market has been categorized into the following segments: fracture recovery, osteoarthritis & degenerative arthritis, spinal fusion, soft-tissue injuries, and maxillofacial & dental applications. Amongst these, the spinal fusion segment is expected to grow at highest CAGR during the forecast period owing to factors such as the rising number of spinal fusion procedures, increasing adoption of allografts & BMAC as part of adjuvant therapy during spinal fusion procedures, & extensive use of stem cells for bone regeneration and bone grafting procedures.
“Hospitals, orthopedic clinics, and ambulatory care centers are expected to be the fastest-growing segment.”
On the basis of end user, the market is segmented into hospitals, orthopedic clinics, and ambulatory care centers; research & academic institutes; and dental clinics and facilities. The hospitals, orthopedic clinics, and ambulatory care centers segment is expected to grow at the highest rate during the forecast period. This can be attributed to the growing geriatric population (coupled with the increasing number of spinal fusion surgeries performed); road accident injuries and bone fractures; growing prevalence of spinal disorders; and growing awareness of products.
“Asia Pacific is expected to register the highest growth rate in the orthobiologics market.”
Geographically, the orthobiologics market is segmented into North America, Europe, Asia Pacific, and RoW. The Asia Pacific market is expected to register the highest growth rate during the forecast period. The presence of a large geriatric and target patient population, high incidence of osteoarthritis and obesity, increasing government spending on healthcare, and improving healthcare infrastructure are some of the major factors driving the growth of the Asia Pacific orthobiologics market.
Breakdown of supply-side primary interviews:
• By Company Type - Tier 1 – 25%, Tier 2 – 30% and Tier 3 – 45%
• By Designation – – C-level – 26%, Director level – 30%, Others – 44%
• By Region – North America - 34%, Europe – 26%, APAC – 23%, RoW – 17%
The major players in the market included are DePuy Synthes, Medtronic, Stryker, Zimmer Biomet, Harvest Technologies, and Globus Medical.
This report studies the orthobiologics market based on product, application, and end user. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends. The report forecasts the revenue of the market segments with respect to four main regions and respective countries.
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis—industry trends, market share analysis of top players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging segments of the orthobiologics market, and high-growth regions and their drivers, restraints, challenges, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies for strengthening their market shares.